Open sidebar
Focus
molnupiravir
COVID Treatments & Remedies
|
Aldgra Fredly
Study Finds Paxlovid, Molnupiravir Reduce Omicron Hospitalization, Mortality
Researchers said that both oral antiviral drugs can be used to treat nonhospitalized patients at high risk of progressing to severe COVID-19.
Sep 22, 2023
|
Aldgra Fredly
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Sep 22
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
COVID News
|
Katabella Roberts
Merck’s COVID-19 Antiviral Drug Doesn’t Reduce Hospitalization or Death in High-Risk Vaccinated People: Study
Dec 26, 2022
|
Katabella Roberts
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Dec 26
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Research & Discoveries
|
Liane Lau
Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients
Oct 11, 2022
|
Liane Lau
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oct 11
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health Viewpoints
|
Joseph Mercola
COVID Pills Cause Deadly Relapses and Supercharge Mutations
May 11, 2022
|
Joseph Mercola
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
May 11
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Businesses in COVID-19
|
Reuters
Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
Feb 04, 2022
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Feb 04
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
|
Reuters
Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron
Jan 12, 2022
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Jan 12
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Businesses in COVID-19
|
Naveen Athrappully
Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills
Jan 05, 2022
|
Naveen Athrappully
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Jan 05
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
India News
|
Reuters
India Boosts Arsenal Against COVID-19 With Merck Pill, 2 More Vaccines
Dec 29, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Dec 29
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
|
Reuters
France Cancels Order for Merck’s COVID-19 Antiviral Drug
Dec 24, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Dec 24
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
US News
|
Mimi Nguyen Ly
FDA Advisers Vote to Recommend Merck COVID-19 Pill for Emergency Use Authorization
Nov 30, 2021
|
Mimi Nguyen Ly
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Nov 30
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Health
|
Reuters
WHO Says Seeks More Data From Merck on COVID-19 Anti-Viral, From Bharat on Vaccine
Oct 29, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oct 29
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
CCP Virus
|
The Associated Press
Merck Asks EU Regulator to Authorize Pill That Treats COVID-19
Oct 25, 2021
|
The Associated Press
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oct 25
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email